|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 06-17 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 06-17 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 133M 123M 114M 215M 14.54B 219M 1.47B 577M 7.14B 570M 558M 24.65B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 113M 105M 96.21M 182M 12.32B 186M 1.25B 489M 6.05B 483M 473M 20.89B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 1 month | +0.09% | ||
| 3 months | +30.41% | ||
| 6 months | +127.38% | ||
| Current year | +159.10% |
| 1 month | 23.48 | 23.5 | |
| Current year | 9.11 | 23.5 | |
| 1 year | 8.61 | 23.5 | |
| 3 years | 7.71 | 86.7 | |
| 5 years | 7.71 | 120.15 | |
| 10 years | 7.71 | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Tender | Chief Executive Officer | -69,691 | 1.0784% | ||
| 06-16 | Tender | Chief Financial Officer | -114,019 | 1.7644% | ||
| 06-16 | Tender | Director | -38,766 | 0.5999% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | -.--% | +126.72% | -69.46% | 152M | ||
| -0.56% | -1.52% | +49.04% | +171.88% | 1,054B | ||
| +0.31% | -0.60% | +64.29% | +62.31% | 621B | ||
| -0.03% | -2.65% | +28.86% | +85.64% | 438B | ||
| -0.23% | -2.83% | +28.02% | +21.64% | 325B | ||
| -0.63% | -2.38% | +28.36% | +45.69% | 281B | ||
| -0.32% | -12.48% | +17.91% | +21.77% | 262B | ||
| -1.39% | -1.97% | -27.58% | -39.63% | 219B | ||
| -0.81% | -1.63% | +22.07% | +58.33% | 195B | ||
| +1.21% | +1.38% | +19.85% | +71.29% | 163B | ||
| Average | -0.19% | -1.50% | +35.75% | +42.95% | 355.64B | |
| Weighted average by Cap. | -0.23% | -1.69% | +35.84% | +83.56% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 351K 325K 299K 566K 38.28M 577K 3.87M 1.52M 18.8M 1.5M 1.47M 64.93M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions

















